view bucket

view bucket

Rs.39.95/Pack
Rs 47.00

Rs.39.95/nebulizer solution

1 nebulizer solution(s)/Pack

Pack Size : 1 Vial x 1ml nebulizer solution

Rs.47 Total

Optra 250mcg nebulizer solution

Optra 250mcg nebulizer solution is composed of

Ipratropium Bromide (250mcg)

Primarily used for

Asthma Lung diseases

Belongs to the category

Bronchodilator + Anti-Asthma

Precaution:

This medicine's use should be closely monitored in conditons like glaucoma (Increased intraoccular eye pressure), prostatic hypertrophy (increased number of prostate gland cells) and bladder outlet obstruction (bladder outflow blockage). Protect eyes from this medicine as it may cause irriation. 

Explore alternate brands

Ipratec 250mcg nebulizer solution

Rs.250.58/nebulizer solution

Highnoon

433.15% Pricey

Atem 250mcg nebulizer solution

Rs.88.2/nebulizer solution

Chiesi

87.66% Pricey

  • hbl-logo
  • 20% OFF
  • meezan-logo
  • 20% OFF
  • alfalah-logo
  • 20% OFF
  • cash-logo
  • 15% OFF

usesUses of Optra

This medicine is used for the prevention and treatment of shortness of breath in patients with Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis and mild to moderate asthma.

side-effectsSide effects of Optra

Patients administered with this medication may experience headache, dizziness, throat irritation, cough, dry mouth, and nausea. Patients may also experience constipation, urinary retention (inability to urinate completely), occasional paradoxical bronchospasm (narrowing or spasm of airway), tachycardia (increased heart rate), and arrhythmias (disorder of heart rhythm)

pillsWhen not to use Optra

This medication is contraindicated in case of hypersensitivity to the active substance i.e. ipratropium bromide or to atropine. 

pills Expert Advice for Optra

Indications:

This medicine is used for the prevention and treatment of shortness of breath in patients with Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis and mild to moderate asthma.

Administration:

This medicine is used with a nebulizer, a machine which changes the solution form into a gaseous form. This gas/mist is then inhaled. The solution must be colorless. Each treatment session usually takes 5-15 minutes.

Make sure to clean the nebulizer to prevent infections. The dosage of this medicine is dependent on the patient’s age, condition and its severity. Please consult your health care provider before use of this medicine.

 

Storage:

Please store this medicine at room temperature (20-30 Celsius). Keep medicine away from excessive light, moisture, and children.

 

 

 

Side Effects:

Patients administered with this medication may experience headache, dizziness, throat irritation, cough, dry mouth, and nausea. Patients may also experience constipation, urinary retention (inability to urinate completely), occasional paradoxical bronchospasm (narrowing or spasm of airway), tachycardia (increased heart rate), and arrhythmias (disorder of heart rhythm)

Precautions:

This medicine's use should be closely monitored in conditons like glaucoma (Increased intraoccular eye pressure), prostatic hypertrophy (increased number of prostate gland cells) and bladder outlet obstruction (bladder outflow blockage). Protect eyes from this medicine as it may cause irriation. 

 

Effects on pregnancy and lactation:

The effects are undetermined; therefore, caution is advised. Please consult your health care provider before use.

 

Contraindications:

This medication is contraindicated in case of hypersensitivity to the active substance i.e. ipratropium bromide or to atropine. 

Q: Does continuous administration of the medicine result in damage within the mouth?
Q: Can we self-administer this medicine?
Q: Does this medicine have severe side effects?
Q: Indications:
Q: Administration:
Q: Storage:
Q: Side Effects:
Q: Precautions:
Q: Effects on pregnancy and lactation:

Warnings

  • pregnant

    Pregnancy

    The effects are underdetermined in pregnancy. Please consult your doctor.

  • mother

    Breast Feeding

    The effects are underdetermined in lactating females. Please consult your doctor.

Number of survey's Available: 0